Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 10/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.31 |
| ▸ | ITK | Q08881 | 2/20 | 0.30 |
| ▸ | BTK | Q06187 | 1/20 | 0.30 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.30 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.30 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.30 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.30 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.30 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.30 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4249862 | 0.83 | MAPK1 (0.36) | MAPK1 | |
| SCHEMBL4582672 | 0.81 | ATM (0.33) | — | |
| SCHEMBL4539815 | 0.79 | REN (0.34) | — | |
| SCHEMBL16076615 | 0.68 | KIF11 (0.47) | KDM4ESMN1; SMN2ADORA2AADORA2BITK | |
| SCHEMBL23627129 | 0.66 | SCN10A (0.41) | MAPK1ADORA2AADORA2B | |
| SCHEMBL13266368 | 0.65 | ADORA2A (0.40) | MAPK1ADORA2AADORA2BITK | |
| SCHEMBL1144940 | 0.60 | KDM4E (0.50) | KDM4ESMN1; SMN2MAPK1ADORA2AADORA2B | |
| SCHEMBL3155790 | 0.59 | CHEK1 (0.50) | SMN1; SMN2ADORA2AADORA2B | |
| SCHEMBL176952 | 0.59 | PDPK1 (0.59) | KDM4EMAPK1ADORA2AADORA2BITK | |
| SCHEMBL4604266 | 0.58 | PRKAG1 (0.44) | KDM4ESMN1; SMN2MAPK1PRKAB2PRKAG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090088576-A1 | Process for the Stereoselective Preparation of Alcohols From Alpha, Beta-Insaturated Compounds | SPEEDEL EXPERIMENTA AG (CH) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090088576-A1 | Process for the Stereoselective Preparation of Alcohols From Alpha, Beta-Insaturated Compounds | ADH1C, ADH1A, EBP | KDM4E 4681/4885SMN1; SMN2 3015/4885MAPK1 2341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.